Your prediction
Pros and Cons of Cytophage Technologies Ltd. in the next few years
Pros
Cons
News
Cytophage Announces Non-Brokered Private Placement
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES
WINNIPEG, October 17, 2025 — Cytophage Technologies Ltd. (“Cytophage” or the “Company”) (TSXV: CYTO, FSE: 70G) today
Cytophage Announces the Commercialization of OvaPhage in Canada Through W.L.T. Distributors Inc.
Winnipeg, Manitoba – October 16, 2025 – Cytophage Technologies Ltd. (“Cytophage” or the “Company”), a biotechnology company developing innovative bacteriophage solutions for animal and human
Cytophage Receives Federal Support for Entry into European Market through France Biomanufacturing Mission
WINNIPEG, September 29, 2025 — Cytophage Technologies Ltd. (“Cytophage” or the “Company”) (TSXV: CYTO, FSE: 70G) announced its participation in the Canadian biomanufacturing mission held in

